Prevalence and correlates of dyslipidemia in HIV positive and negative adults in Western Kenya: A cross-sectional study

There is increasing morbidity and mortality from cardiovascular diseases (CVD) in sub-Saharan Africa (SSA). Dyslipidemia is a well-known CVD risk factor which has been associated with human immunodeficiency virus (HIV) infection and its treatment in high-income countries. Studies in SSA that have ex...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2021-03, Vol.100 (10), p.e24800-e24800
Hauptverfasser: Tilahun, Hailu, Masyuko, Sarah J., Mogaka, Jerusha N., Temu, Tecla, Kinuthia, John, Osoti, Alfred O., Nakanjako, Damalie, Farquhar, Carey, Page, Stephanie T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e24800
container_issue 10
container_start_page e24800
container_title Medicine (Baltimore)
container_volume 100
creator Tilahun, Hailu
Masyuko, Sarah J.
Mogaka, Jerusha N.
Temu, Tecla
Kinuthia, John
Osoti, Alfred O.
Nakanjako, Damalie
Farquhar, Carey
Page, Stephanie T.
description There is increasing morbidity and mortality from cardiovascular diseases (CVD) in sub-Saharan Africa (SSA). Dyslipidemia is a well-known CVD risk factor which has been associated with human immunodeficiency virus (HIV) infection and its treatment in high-income countries. Studies in SSA that have examined the relationship between HIV and dyslipidemia have reported mixed results. In this study, we sought to determine the prevalence of dyslipidemia in HIV positive and negative adults (>=30 years old) and evaluate for association in Western Kenya with a higher prevalence expected among HIV positive individuals.HIV positive adults receiving antiretroviral therapy (ART) and HIV negative individuals seeking HIV testing and counseling services were recruited into a cross-sectional study. Demographic and behavioral data and fasting blood samples were collected. Dyslipidemia was defined according to the National Cholesterol Education Program Adult Treatment Panel III. Associations between baseline demographic and clinical variables and dyslipidemia were analyzed using logistic regression.A total of 598 participants, 300 HIV positive and 298 HIV negative adults were enrolled. Dyslipidemia data was available for 564 (94%) participants. In total, 267 (47%) had dyslipidemia. This was not significantly different between HIV positive and HIV negative individuals (46% vs 49%, P = .4). In a multivariate analysis including both HIV positive and negative individuals, adults 50 to 59 years of age had a 2-fold increased risk of dyslipidemia (Odds ratio [OR] 2.1, 95% confidence interval (1.2-3.5) when compared to 30 to 39-years-old participants. Abdominal obesity (OR 2.5), being overweight (OR 1.9), and low fruit and vegetable intake (OR 2.2) were significantly associated with dyslipidemia. Among HIV positive participants, time since HIV diagnosis, ART duration, use of (PI) protease inhibitor-based ART, viral load suppression, current cluster of differentiation (CD4) count and nadir CD4 did not have significant associations with dyslipidemia.The prevalence of dyslipidemia is high in Western Kenya, with nearly half of all participants with lipid abnormalities. Dyslipidemia was not significantly associated with HIV status, or with HIV-specific factors. Older age, being overweight, abdominal obesity, and low fruit and vegetable intake were associated with dyslipidemia and may be targets for public health interventions to lower the prevalence of dyslipidemia and CVD risk in sub-Sah
doi_str_mv 10.1097/MD.0000000000024800
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7969311</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2502205895</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3558-72c632d3b2cf2b49d8f1b92c51a9516e7d81e8bacfce5a76ea37e9abe7ef74383</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EotuWX4CEfOSS4o84tjkgVS2lFa3ogY-j5TiTrsFrL3ayq_33ZJtSPnwZ2fPMO555EXpJyQklWr65OT8hfw6rFSFP0IIK3lRCN_VTtJheRSW1rA_QYSnfCaFcsvo5OuBTFIrXC7S9zbCxAaIDbGOHXcoZgh2g4NTjbleCX_sOVt5iH_Hl1Ve8TsUPfjPjEe7sfOnGMJQ98w3KADnijxB39i0-xS6nUqoCbvAp2oDLMHa7Y_Sst6HAi4d4hL5cvP98dlldf_pwdXZ6XTkuhKokcw1nHW-Z61lb6071tNXMCWq1oA3ITlFQrXW9A2FlA5ZL0LYFCb2sueJH6N2sux7bFXQO4pBtMOvsVzbvTLLe_JuJfmnu0sZI3WhO6STw-kEgp5_jNJtZ-eIgBBshjcUwQRgjQmkxoXxG7yfO0D-2ocTsLTM35-Z_y6aqV3__8LHmt0cTUM_ANoVps-VHGLeQzRJsGJb3ekJqVjHCKOGUkWovrfgvPsukMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2502205895</pqid></control><display><type>article</type><title>Prevalence and correlates of dyslipidemia in HIV positive and negative adults in Western Kenya: A cross-sectional study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wolters Kluwer Open Health</source><source>IngentaConnect Free/Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Tilahun, Hailu ; Masyuko, Sarah J. ; Mogaka, Jerusha N. ; Temu, Tecla ; Kinuthia, John ; Osoti, Alfred O. ; Nakanjako, Damalie ; Farquhar, Carey ; Page, Stephanie T.</creator><creatorcontrib>Tilahun, Hailu ; Masyuko, Sarah J. ; Mogaka, Jerusha N. ; Temu, Tecla ; Kinuthia, John ; Osoti, Alfred O. ; Nakanjako, Damalie ; Farquhar, Carey ; Page, Stephanie T.</creatorcontrib><description>There is increasing morbidity and mortality from cardiovascular diseases (CVD) in sub-Saharan Africa (SSA). Dyslipidemia is a well-known CVD risk factor which has been associated with human immunodeficiency virus (HIV) infection and its treatment in high-income countries. Studies in SSA that have examined the relationship between HIV and dyslipidemia have reported mixed results. In this study, we sought to determine the prevalence of dyslipidemia in HIV positive and negative adults (&gt;=30 years old) and evaluate for association in Western Kenya with a higher prevalence expected among HIV positive individuals.HIV positive adults receiving antiretroviral therapy (ART) and HIV negative individuals seeking HIV testing and counseling services were recruited into a cross-sectional study. Demographic and behavioral data and fasting blood samples were collected. Dyslipidemia was defined according to the National Cholesterol Education Program Adult Treatment Panel III. Associations between baseline demographic and clinical variables and dyslipidemia were analyzed using logistic regression.A total of 598 participants, 300 HIV positive and 298 HIV negative adults were enrolled. Dyslipidemia data was available for 564 (94%) participants. In total, 267 (47%) had dyslipidemia. This was not significantly different between HIV positive and HIV negative individuals (46% vs 49%, P = .4). In a multivariate analysis including both HIV positive and negative individuals, adults 50 to 59 years of age had a 2-fold increased risk of dyslipidemia (Odds ratio [OR] 2.1, 95% confidence interval (1.2-3.5) when compared to 30 to 39-years-old participants. Abdominal obesity (OR 2.5), being overweight (OR 1.9), and low fruit and vegetable intake (OR 2.2) were significantly associated with dyslipidemia. Among HIV positive participants, time since HIV diagnosis, ART duration, use of (PI) protease inhibitor-based ART, viral load suppression, current cluster of differentiation (CD4) count and nadir CD4 did not have significant associations with dyslipidemia.The prevalence of dyslipidemia is high in Western Kenya, with nearly half of all participants with lipid abnormalities. Dyslipidemia was not significantly associated with HIV status, or with HIV-specific factors. Older age, being overweight, abdominal obesity, and low fruit and vegetable intake were associated with dyslipidemia and may be targets for public health interventions to lower the prevalence of dyslipidemia and CVD risk in sub-Saharan Africa.</description><identifier>ISSN: 0025-7974</identifier><identifier>ISSN: 1536-5964</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000024800</identifier><identifier>PMID: 33725834</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Aged ; Anti-HIV Agents - therapeutic use ; CD4 Lymphocyte Count ; Comorbidity ; Cross-Sectional Studies ; Diet ; Dyslipidemias - epidemiology ; Female ; Fruit ; Heart Disease Risk Factors ; HIV Seropositivity - drug therapy ; HIV Seropositivity - epidemiology ; HIV Seropositivity - immunology ; HIV Seropositivity - virology ; Humans ; Kenya - epidemiology ; Male ; Middle Aged ; Obesity, Abdominal - epidemiology ; Observational Study ; Overweight - epidemiology ; Prevalence ; Vegetables ; Viral Load</subject><ispartof>Medicine (Baltimore), 2021-03, Vol.100 (10), p.e24800-e24800</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><rights>Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3558-72c632d3b2cf2b49d8f1b92c51a9516e7d81e8bacfce5a76ea37e9abe7ef74383</cites><orcidid>0000-0002-0850-0240</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969311/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969311/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33725834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tilahun, Hailu</creatorcontrib><creatorcontrib>Masyuko, Sarah J.</creatorcontrib><creatorcontrib>Mogaka, Jerusha N.</creatorcontrib><creatorcontrib>Temu, Tecla</creatorcontrib><creatorcontrib>Kinuthia, John</creatorcontrib><creatorcontrib>Osoti, Alfred O.</creatorcontrib><creatorcontrib>Nakanjako, Damalie</creatorcontrib><creatorcontrib>Farquhar, Carey</creatorcontrib><creatorcontrib>Page, Stephanie T.</creatorcontrib><title>Prevalence and correlates of dyslipidemia in HIV positive and negative adults in Western Kenya: A cross-sectional study</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>There is increasing morbidity and mortality from cardiovascular diseases (CVD) in sub-Saharan Africa (SSA). Dyslipidemia is a well-known CVD risk factor which has been associated with human immunodeficiency virus (HIV) infection and its treatment in high-income countries. Studies in SSA that have examined the relationship between HIV and dyslipidemia have reported mixed results. In this study, we sought to determine the prevalence of dyslipidemia in HIV positive and negative adults (&gt;=30 years old) and evaluate for association in Western Kenya with a higher prevalence expected among HIV positive individuals.HIV positive adults receiving antiretroviral therapy (ART) and HIV negative individuals seeking HIV testing and counseling services were recruited into a cross-sectional study. Demographic and behavioral data and fasting blood samples were collected. Dyslipidemia was defined according to the National Cholesterol Education Program Adult Treatment Panel III. Associations between baseline demographic and clinical variables and dyslipidemia were analyzed using logistic regression.A total of 598 participants, 300 HIV positive and 298 HIV negative adults were enrolled. Dyslipidemia data was available for 564 (94%) participants. In total, 267 (47%) had dyslipidemia. This was not significantly different between HIV positive and HIV negative individuals (46% vs 49%, P = .4). In a multivariate analysis including both HIV positive and negative individuals, adults 50 to 59 years of age had a 2-fold increased risk of dyslipidemia (Odds ratio [OR] 2.1, 95% confidence interval (1.2-3.5) when compared to 30 to 39-years-old participants. Abdominal obesity (OR 2.5), being overweight (OR 1.9), and low fruit and vegetable intake (OR 2.2) were significantly associated with dyslipidemia. Among HIV positive participants, time since HIV diagnosis, ART duration, use of (PI) protease inhibitor-based ART, viral load suppression, current cluster of differentiation (CD4) count and nadir CD4 did not have significant associations with dyslipidemia.The prevalence of dyslipidemia is high in Western Kenya, with nearly half of all participants with lipid abnormalities. Dyslipidemia was not significantly associated with HIV status, or with HIV-specific factors. Older age, being overweight, abdominal obesity, and low fruit and vegetable intake were associated with dyslipidemia and may be targets for public health interventions to lower the prevalence of dyslipidemia and CVD risk in sub-Saharan Africa.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>CD4 Lymphocyte Count</subject><subject>Comorbidity</subject><subject>Cross-Sectional Studies</subject><subject>Diet</subject><subject>Dyslipidemias - epidemiology</subject><subject>Female</subject><subject>Fruit</subject><subject>Heart Disease Risk Factors</subject><subject>HIV Seropositivity - drug therapy</subject><subject>HIV Seropositivity - epidemiology</subject><subject>HIV Seropositivity - immunology</subject><subject>HIV Seropositivity - virology</subject><subject>Humans</subject><subject>Kenya - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Obesity, Abdominal - epidemiology</subject><subject>Observational Study</subject><subject>Overweight - epidemiology</subject><subject>Prevalence</subject><subject>Vegetables</subject><subject>Viral Load</subject><issn>0025-7974</issn><issn>1536-5964</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhi0EotuWX4CEfOSS4o84tjkgVS2lFa3ogY-j5TiTrsFrL3ayq_33ZJtSPnwZ2fPMO555EXpJyQklWr65OT8hfw6rFSFP0IIK3lRCN_VTtJheRSW1rA_QYSnfCaFcsvo5OuBTFIrXC7S9zbCxAaIDbGOHXcoZgh2g4NTjbleCX_sOVt5iH_Hl1Ve8TsUPfjPjEe7sfOnGMJQ98w3KADnijxB39i0-xS6nUqoCbvAp2oDLMHa7Y_Sst6HAi4d4hL5cvP98dlldf_pwdXZ6XTkuhKokcw1nHW-Z61lb6071tNXMCWq1oA3ITlFQrXW9A2FlA5ZL0LYFCb2sueJH6N2sux7bFXQO4pBtMOvsVzbvTLLe_JuJfmnu0sZI3WhO6STw-kEgp5_jNJtZ-eIgBBshjcUwQRgjQmkxoXxG7yfO0D-2ocTsLTM35-Z_y6aqV3__8LHmt0cTUM_ANoVps-VHGLeQzRJsGJb3ekJqVjHCKOGUkWovrfgvPsukMw</recordid><startdate>20210312</startdate><enddate>20210312</enddate><creator>Tilahun, Hailu</creator><creator>Masyuko, Sarah J.</creator><creator>Mogaka, Jerusha N.</creator><creator>Temu, Tecla</creator><creator>Kinuthia, John</creator><creator>Osoti, Alfred O.</creator><creator>Nakanjako, Damalie</creator><creator>Farquhar, Carey</creator><creator>Page, Stephanie T.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0850-0240</orcidid></search><sort><creationdate>20210312</creationdate><title>Prevalence and correlates of dyslipidemia in HIV positive and negative adults in Western Kenya: A cross-sectional study</title><author>Tilahun, Hailu ; Masyuko, Sarah J. ; Mogaka, Jerusha N. ; Temu, Tecla ; Kinuthia, John ; Osoti, Alfred O. ; Nakanjako, Damalie ; Farquhar, Carey ; Page, Stephanie T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3558-72c632d3b2cf2b49d8f1b92c51a9516e7d81e8bacfce5a76ea37e9abe7ef74383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>CD4 Lymphocyte Count</topic><topic>Comorbidity</topic><topic>Cross-Sectional Studies</topic><topic>Diet</topic><topic>Dyslipidemias - epidemiology</topic><topic>Female</topic><topic>Fruit</topic><topic>Heart Disease Risk Factors</topic><topic>HIV Seropositivity - drug therapy</topic><topic>HIV Seropositivity - epidemiology</topic><topic>HIV Seropositivity - immunology</topic><topic>HIV Seropositivity - virology</topic><topic>Humans</topic><topic>Kenya - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Obesity, Abdominal - epidemiology</topic><topic>Observational Study</topic><topic>Overweight - epidemiology</topic><topic>Prevalence</topic><topic>Vegetables</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tilahun, Hailu</creatorcontrib><creatorcontrib>Masyuko, Sarah J.</creatorcontrib><creatorcontrib>Mogaka, Jerusha N.</creatorcontrib><creatorcontrib>Temu, Tecla</creatorcontrib><creatorcontrib>Kinuthia, John</creatorcontrib><creatorcontrib>Osoti, Alfred O.</creatorcontrib><creatorcontrib>Nakanjako, Damalie</creatorcontrib><creatorcontrib>Farquhar, Carey</creatorcontrib><creatorcontrib>Page, Stephanie T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tilahun, Hailu</au><au>Masyuko, Sarah J.</au><au>Mogaka, Jerusha N.</au><au>Temu, Tecla</au><au>Kinuthia, John</au><au>Osoti, Alfred O.</au><au>Nakanjako, Damalie</au><au>Farquhar, Carey</au><au>Page, Stephanie T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and correlates of dyslipidemia in HIV positive and negative adults in Western Kenya: A cross-sectional study</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2021-03-12</date><risdate>2021</risdate><volume>100</volume><issue>10</issue><spage>e24800</spage><epage>e24800</epage><pages>e24800-e24800</pages><issn>0025-7974</issn><issn>1536-5964</issn><eissn>1536-5964</eissn><abstract>There is increasing morbidity and mortality from cardiovascular diseases (CVD) in sub-Saharan Africa (SSA). Dyslipidemia is a well-known CVD risk factor which has been associated with human immunodeficiency virus (HIV) infection and its treatment in high-income countries. Studies in SSA that have examined the relationship between HIV and dyslipidemia have reported mixed results. In this study, we sought to determine the prevalence of dyslipidemia in HIV positive and negative adults (&gt;=30 years old) and evaluate for association in Western Kenya with a higher prevalence expected among HIV positive individuals.HIV positive adults receiving antiretroviral therapy (ART) and HIV negative individuals seeking HIV testing and counseling services were recruited into a cross-sectional study. Demographic and behavioral data and fasting blood samples were collected. Dyslipidemia was defined according to the National Cholesterol Education Program Adult Treatment Panel III. Associations between baseline demographic and clinical variables and dyslipidemia were analyzed using logistic regression.A total of 598 participants, 300 HIV positive and 298 HIV negative adults were enrolled. Dyslipidemia data was available for 564 (94%) participants. In total, 267 (47%) had dyslipidemia. This was not significantly different between HIV positive and HIV negative individuals (46% vs 49%, P = .4). In a multivariate analysis including both HIV positive and negative individuals, adults 50 to 59 years of age had a 2-fold increased risk of dyslipidemia (Odds ratio [OR] 2.1, 95% confidence interval (1.2-3.5) when compared to 30 to 39-years-old participants. Abdominal obesity (OR 2.5), being overweight (OR 1.9), and low fruit and vegetable intake (OR 2.2) were significantly associated with dyslipidemia. Among HIV positive participants, time since HIV diagnosis, ART duration, use of (PI) protease inhibitor-based ART, viral load suppression, current cluster of differentiation (CD4) count and nadir CD4 did not have significant associations with dyslipidemia.The prevalence of dyslipidemia is high in Western Kenya, with nearly half of all participants with lipid abnormalities. Dyslipidemia was not significantly associated with HIV status, or with HIV-specific factors. Older age, being overweight, abdominal obesity, and low fruit and vegetable intake were associated with dyslipidemia and may be targets for public health interventions to lower the prevalence of dyslipidemia and CVD risk in sub-Saharan Africa.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>33725834</pmid><doi>10.1097/MD.0000000000024800</doi><orcidid>https://orcid.org/0000-0002-0850-0240</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2021-03, Vol.100 (10), p.e24800-e24800
issn 0025-7974
1536-5964
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7969311
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wolters Kluwer Open Health; IngentaConnect Free/Open Access Journals; PubMed Central; Alma/SFX Local Collection
subjects Adult
Aged
Anti-HIV Agents - therapeutic use
CD4 Lymphocyte Count
Comorbidity
Cross-Sectional Studies
Diet
Dyslipidemias - epidemiology
Female
Fruit
Heart Disease Risk Factors
HIV Seropositivity - drug therapy
HIV Seropositivity - epidemiology
HIV Seropositivity - immunology
HIV Seropositivity - virology
Humans
Kenya - epidemiology
Male
Middle Aged
Obesity, Abdominal - epidemiology
Observational Study
Overweight - epidemiology
Prevalence
Vegetables
Viral Load
title Prevalence and correlates of dyslipidemia in HIV positive and negative adults in Western Kenya: A cross-sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A31%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20correlates%20of%20dyslipidemia%20in%20HIV%20positive%20and%20negative%20adults%20in%20Western%20Kenya:%20A%20cross-sectional%20study&rft.jtitle=Medicine%20(Baltimore)&rft.au=Tilahun,%20Hailu&rft.date=2021-03-12&rft.volume=100&rft.issue=10&rft.spage=e24800&rft.epage=e24800&rft.pages=e24800-e24800&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000024800&rft_dat=%3Cproquest_pubme%3E2502205895%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2502205895&rft_id=info:pmid/33725834&rfr_iscdi=true